 Jason Weinman
Concepts (201)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tomography, X-Ray Computed | 26 | 2024 | 2691 | 3.400 |
Why?
| | Radiation Dosage | 6 | 2025 | 179 | 2.200 |
Why?
| | Phantoms, Imaging | 2 | 2024 | 152 | 1.630 |
Why?
| | Lung Diseases, Interstitial | 9 | 2024 | 638 | 1.560 |
Why?
| | Glycogen Storage Disease | 4 | 2021 | 19 | 1.070 |
Why?
| | Hypertension, Pulmonary | 7 | 2024 | 1910 | 0.970 |
Why?
| | Radiography, Abdominal | 1 | 2024 | 45 | 0.850 |
Why?
| | Lung Diseases | 4 | 2022 | 767 | 0.780 |
Why?
| | Bronchiolitis Obliterans | 2 | 2021 | 69 | 0.730 |
Why?
| | Pulmonary Surfactant-Associated Protein C | 1 | 2021 | 45 | 0.700 |
Why?
| | Protein C | 1 | 2021 | 59 | 0.690 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 3 | 2025 | 110 | 0.670 |
Why?
| | Athetosis | 1 | 2019 | 7 | 0.620 |
Why?
| | Thyroid Nuclear Factor 1 | 1 | 2019 | 16 | 0.620 |
Why?
| | Congenital Hypothyroidism | 1 | 2019 | 11 | 0.620 |
Why?
| | Chorea | 1 | 2019 | 13 | 0.620 |
Why?
| | Child | 30 | 2025 | 21935 | 0.620 |
Why?
| | Pulmonary Eosinophilia | 1 | 2018 | 27 | 0.590 |
Why?
| | Silicosis | 1 | 2018 | 27 | 0.580 |
Why?
| | Computed Tomography Angiography | 3 | 2025 | 129 | 0.570 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2019 | 106 | 0.570 |
Why?
| | Head | 1 | 2019 | 105 | 0.560 |
Why?
| | Alveolitis, Extrinsic Allergic | 1 | 2018 | 97 | 0.560 |
Why?
| | Heart Defects, Congenital | 6 | 2025 | 842 | 0.520 |
Why?
| | Bronchiolitis | 1 | 2017 | 80 | 0.510 |
Why?
| | Bronchiectasis | 3 | 2024 | 111 | 0.500 |
Why?
| | Photons | 3 | 2025 | 70 | 0.490 |
Why?
| | Infant, Newborn | 12 | 2024 | 6079 | 0.470 |
Why?
| | Spondylolysis | 1 | 2015 | 7 | 0.470 |
Why?
| | Child, Preschool | 16 | 2025 | 11074 | 0.470 |
Why?
| | Marijuana Smoking | 1 | 2018 | 252 | 0.460 |
Why?
| | Imaging, Three-Dimensional | 2 | 2018 | 580 | 0.450 |
Why?
| | Bone Cysts | 1 | 2013 | 9 | 0.410 |
Why?
| | Infant | 18 | 2025 | 9465 | 0.400 |
Why?
| | Humans | 52 | 2025 | 137585 | 0.400 |
Why?
| | Coronary Angiography | 2 | 2025 | 317 | 0.370 |
Why?
| | Retrospective Studies | 21 | 2025 | 15657 | 0.360 |
Why?
| | Biopsy | 4 | 2018 | 1129 | 0.360 |
Why?
| | Pediatrics | 1 | 2019 | 1101 | 0.340 |
Why?
| | Lung | 10 | 2024 | 4060 | 0.340 |
Why?
| | Pulmonary Edema | 2 | 2022 | 108 | 0.330 |
Why?
| | Male | 27 | 2025 | 67762 | 0.320 |
Why?
| | Coronary Vessels | 2 | 2022 | 248 | 0.320 |
Why?
| | Altitude Sickness | 2 | 2022 | 153 | 0.300 |
Why?
| | Respiratory Insufficiency | 2 | 2023 | 318 | 0.300 |
Why?
| | Brain | 1 | 2019 | 2668 | 0.260 |
Why?
| | Mutation | 4 | 2024 | 3958 | 0.260 |
Why?
| | Female | 25 | 2025 | 73304 | 0.250 |
Why?
| | Adolescent | 13 | 2025 | 21513 | 0.250 |
Why?
| | Pulmonary Alveoli | 4 | 2021 | 405 | 0.250 |
Why?
| | Pulmonary Artery | 3 | 2024 | 1086 | 0.250 |
Why?
| | Reproducibility of Results | 4 | 2024 | 3284 | 0.240 |
Why?
| | Submandibular Gland | 1 | 2025 | 20 | 0.240 |
Why?
| | Radiography | 3 | 2018 | 822 | 0.240 |
Why?
| | Interleukin-5 | 1 | 2025 | 44 | 0.230 |
Why?
| | Churg-Strauss Syndrome | 1 | 2025 | 26 | 0.230 |
Why?
| | Familial Primary Pulmonary Hypertension | 2 | 2024 | 198 | 0.230 |
Why?
| | Lupus Nephritis | 1 | 2025 | 63 | 0.230 |
Why?
| | Class I Phosphatidylinositol 3-Kinases | 1 | 2025 | 95 | 0.230 |
Why?
| | Trachea | 3 | 2020 | 237 | 0.220 |
Why?
| | Body Size | 1 | 2024 | 108 | 0.210 |
Why?
| | Tin | 1 | 2023 | 9 | 0.210 |
Why?
| | Stenosis, Pulmonary Vein | 1 | 2023 | 17 | 0.200 |
Why?
| | Pulmonary Atresia | 1 | 2022 | 21 | 0.190 |
Why?
| | Abdominal Abscess | 1 | 2022 | 27 | 0.190 |
Why?
| | Sensitivity and Specificity | 2 | 2024 | 1946 | 0.190 |
Why?
| | Bone Morphogenetic Protein Receptors, Type II | 1 | 2022 | 51 | 0.190 |
Why?
| | Pulmonary Veins | 1 | 2023 | 99 | 0.190 |
Why?
| | Coronary Circulation | 1 | 2022 | 143 | 0.190 |
Why?
| | Antibodies, Monoclonal, Humanized | 2 | 2025 | 804 | 0.190 |
Why?
| | Fractures, Bone | 2 | 2017 | 380 | 0.180 |
Why?
| | Social Norms | 1 | 2022 | 29 | 0.180 |
Why?
| | Bronchi | 2 | 2023 | 260 | 0.180 |
Why?
| | Precision Medicine | 1 | 2025 | 429 | 0.180 |
Why?
| | Sexism | 1 | 2022 | 61 | 0.180 |
Why?
| | Pleural Effusion | 1 | 2021 | 54 | 0.180 |
Why?
| | Stevens-Johnson Syndrome | 1 | 2021 | 39 | 0.170 |
Why?
| | Pulmonary Fibrosis | 1 | 2024 | 402 | 0.170 |
Why?
| | Esophageal Atresia | 1 | 2020 | 26 | 0.170 |
Why?
| | Surface-Active Agents | 1 | 2021 | 91 | 0.170 |
Why?
| | Body Surface Area | 1 | 2020 | 34 | 0.170 |
Why?
| | Cardiac-Gated Imaging Techniques | 1 | 2020 | 21 | 0.170 |
Why?
| | Tracheoesophageal Fistula | 1 | 2020 | 33 | 0.170 |
Why?
| | Psoriasis | 1 | 2021 | 102 | 0.170 |
Why?
| | Vaping | 1 | 2021 | 60 | 0.170 |
Why?
| | Vasculitis | 1 | 2021 | 66 | 0.170 |
Why?
| | Mucolipidoses | 1 | 2020 | 7 | 0.170 |
Why?
| | Joint Diseases | 1 | 2021 | 60 | 0.170 |
Why?
| | Hemorrhage | 2 | 2021 | 722 | 0.160 |
Why?
| | Electronic Nicotine Delivery Systems | 1 | 2021 | 103 | 0.160 |
Why?
| | Autoimmune Diseases | 1 | 2024 | 460 | 0.160 |
Why?
| | Fracture Healing | 2 | 2017 | 79 | 0.160 |
Why?
| | Renal Insufficiency | 1 | 2021 | 162 | 0.160 |
Why?
| | Echocardiography | 1 | 2022 | 642 | 0.150 |
Why?
| | Death, Sudden | 1 | 2019 | 24 | 0.150 |
Why?
| | Signal-To-Noise Ratio | 1 | 2019 | 67 | 0.150 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2021 | 622 | 0.150 |
Why?
| | Lung Injury | 1 | 2021 | 219 | 0.150 |
Why?
| | Crohn Disease | 1 | 2022 | 243 | 0.150 |
Why?
| | Altitude | 2 | 2022 | 488 | 0.150 |
Why?
| | Neuroendocrine Cells | 1 | 2018 | 32 | 0.140 |
Why?
| | Bronchioles | 1 | 2018 | 23 | 0.140 |
Why?
| | Bronchopulmonary Dysplasia | 1 | 2023 | 383 | 0.140 |
Why?
| | Vascular Diseases | 1 | 2020 | 243 | 0.140 |
Why?
| | Respiration Disorders | 1 | 2018 | 77 | 0.140 |
Why?
| | Pneumonia, Lipid | 1 | 2017 | 3 | 0.140 |
Why?
| | Multiple Pulmonary Nodules | 1 | 2017 | 23 | 0.140 |
Why?
| | Arteriovenous Anastomosis | 1 | 2017 | 13 | 0.140 |
Why?
| | Bronchial Arteries | 1 | 2017 | 12 | 0.140 |
Why?
| | Magnetic Resonance Imaging | 2 | 2023 | 3566 | 0.140 |
Why?
| | Radiation Exposure | 1 | 2017 | 49 | 0.140 |
Why?
| | Socioeconomic Factors | 1 | 2022 | 1289 | 0.130 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2031 | 0.130 |
Why?
| | Airway Obstruction | 1 | 2019 | 162 | 0.130 |
Why?
| | Anti-Asthmatic Agents | 1 | 2021 | 395 | 0.130 |
Why?
| | Birth Injuries | 1 | 2016 | 9 | 0.130 |
Why?
| | Respiratory Function Tests | 1 | 2018 | 600 | 0.130 |
Why?
| | Idiopathic Pulmonary Fibrosis | 1 | 2024 | 657 | 0.130 |
Why?
| | Clavicle | 1 | 2016 | 33 | 0.130 |
Why?
| | Bone Remodeling | 1 | 2017 | 75 | 0.130 |
Why?
| | Comorbidity | 2 | 2020 | 1622 | 0.130 |
Why?
| | Gastrointestinal Diseases | 1 | 2018 | 209 | 0.130 |
Why?
| | Heart Rate | 1 | 2020 | 822 | 0.130 |
Why?
| | Upper Extremity | 1 | 2017 | 99 | 0.120 |
Why?
| | Anemia, Sickle Cell | 1 | 2019 | 270 | 0.120 |
Why?
| | Lymphangiectasis | 1 | 2014 | 4 | 0.110 |
Why?
| | Lymphangiectasis, Intestinal | 1 | 2014 | 6 | 0.110 |
Why?
| | Lumbosacral Region | 1 | 2015 | 58 | 0.110 |
Why?
| | Wounds and Injuries | 1 | 2022 | 758 | 0.110 |
Why?
| | Down Syndrome | 1 | 2021 | 496 | 0.110 |
Why?
| | Child Abuse | 2 | 2017 | 535 | 0.110 |
Why?
| | Kidney Neoplasms | 1 | 2017 | 403 | 0.100 |
Why?
| | Diagnosis, Differential | 1 | 2017 | 1483 | 0.100 |
Why?
| | Humerus | 1 | 2013 | 39 | 0.100 |
Why?
| | Lumbar Vertebrae | 1 | 2015 | 246 | 0.100 |
Why?
| | Lower Extremity | 1 | 2017 | 427 | 0.100 |
Why?
| | Cross-Sectional Studies | 5 | 2022 | 5472 | 0.090 |
Why?
| | Postoperative Care | 1 | 2013 | 261 | 0.090 |
Why?
| | Femur | 1 | 2013 | 254 | 0.090 |
Why?
| | Hypoxia | 1 | 2017 | 1112 | 0.080 |
Why?
| | Bronchoscopy | 2 | 2020 | 223 | 0.080 |
Why?
| | Pandemics | 3 | 2022 | 1639 | 0.070 |
Why?
| | Heart Failure | 1 | 2021 | 2236 | 0.070 |
Why?
| | Asthma | 1 | 2021 | 2295 | 0.070 |
Why?
| | Nephrocalcinosis | 1 | 2025 | 13 | 0.060 |
Why?
| | Adult | 3 | 2024 | 37929 | 0.060 |
Why?
| | Prospective Studies | 3 | 2022 | 7604 | 0.050 |
Why?
| | Young Adult | 4 | 2023 | 13209 | 0.050 |
Why?
| | Prognosis | 2 | 2024 | 4030 | 0.050 |
Why?
| | T-Box Domain Proteins | 1 | 2024 | 98 | 0.050 |
Why?
| | Fibrin | 1 | 2023 | 81 | 0.050 |
Why?
| | Cellulitis | 1 | 2022 | 53 | 0.050 |
Why?
| | Infliximab | 1 | 2022 | 111 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2022 | 115 | 0.050 |
Why?
| | Necrosis | 1 | 2022 | 246 | 0.040 |
Why?
| | Glucocorticoids | 1 | 2025 | 594 | 0.040 |
Why?
| | Transforming Growth Factor beta | 1 | 2003 | 480 | 0.040 |
Why?
| | Granuloma | 1 | 2021 | 92 | 0.040 |
Why?
| | Interleukin-1 | 1 | 2003 | 965 | 0.040 |
Why?
| | Autoimmunity | 1 | 2025 | 908 | 0.040 |
Why?
| | Ultrasonography | 1 | 2023 | 759 | 0.040 |
Why?
| | Trauma Centers | 1 | 2022 | 421 | 0.040 |
Why?
| | Cardiac Catheterization | 1 | 2022 | 530 | 0.040 |
Why?
| | Heart | 1 | 2023 | 655 | 0.040 |
Why?
| | Esophageal pH Monitoring | 1 | 2018 | 23 | 0.040 |
Why?
| | Infant, Premature | 1 | 2023 | 574 | 0.040 |
Why?
| | Electric Impedance | 1 | 2018 | 107 | 0.040 |
Why?
| | Eosinophils | 1 | 2021 | 332 | 0.040 |
Why?
| | Fatal Outcome | 1 | 2019 | 303 | 0.040 |
Why?
| | Hyperplasia | 1 | 2018 | 175 | 0.030 |
Why?
| | Feasibility Studies | 1 | 2022 | 956 | 0.030 |
Why?
| | Rare Diseases | 1 | 2018 | 104 | 0.030 |
Why?
| | Kidney | 1 | 2025 | 1468 | 0.030 |
Why?
| | Macrophage Activation Syndrome | 1 | 2017 | 22 | 0.030 |
Why?
| | Unnecessary Procedures | 1 | 2017 | 50 | 0.030 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2022 | 1242 | 0.030 |
Why?
| | Bony Callus | 1 | 2016 | 5 | 0.030 |
Why?
| | Arthritis, Juvenile | 1 | 2017 | 56 | 0.030 |
Why?
| | Ambulatory Care Facilities | 1 | 2018 | 232 | 0.030 |
Why?
| | Respiration, Artificial | 1 | 2021 | 645 | 0.030 |
Why?
| | Prevalence | 1 | 2023 | 2734 | 0.030 |
Why?
| | Observer Variation | 1 | 2016 | 343 | 0.030 |
Why?
| | Gestational Age | 1 | 2018 | 910 | 0.030 |
Why?
| | Adrenal Cortex Hormones | 1 | 2018 | 565 | 0.030 |
Why?
| | Incidence | 1 | 2020 | 2804 | 0.030 |
Why?
| | Colorado | 1 | 2022 | 4565 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 10811 | 0.020 |
Why?
| | Phenotype | 1 | 2018 | 3196 | 0.020 |
Why?
| | Chemokines, CXC | 1 | 2003 | 70 | 0.010 |
Why?
| | Peroxidase | 1 | 2003 | 175 | 0.010 |
Why?
| | Leukocyte Count | 1 | 2003 | 329 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2003 | 382 | 0.010 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2003 | 652 | 0.010 |
Why?
| | Recombinant Proteins | 1 | 2003 | 1353 | 0.010 |
Why?
| | Oxygen | 1 | 2003 | 931 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2003 | 2486 | 0.010 |
Why?
| | Neutrophils | 1 | 2003 | 1238 | 0.010 |
Why?
| | Antibodies, Monoclonal | 1 | 2003 | 1430 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2003 | 4193 | 0.010 |
Why?
| | Rats | 1 | 2003 | 5647 | 0.010 |
Why?
| | Animals | 1 | 2003 | 36940 | 0.000 |
Why?
|
|
Weinman's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|